EUVIMEDEUVIMED entdecken
Crossref

Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo‐obstruction: A single‐center analysis

Teresa Capriati iD, Roberto De Giorgio, Fabrizio Chiusolo, Renato Tambucci, Fabio Fusaro, Tamara Caldaro, Chiara Maria Trovato, Elena Bonora, Antonella Diamanti

Journal of Pediatric Gastroenterology and Nutrition · 2025

DOI: 10.1002/jpn3.70171 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2025. Verfasst von Teresa Capriati und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Nutritional Rehabilitation, "Bambino Gesù" Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Pyridostigmine Bromide, Intestinal Pseudo-Obstruction, Enteral Nutrition, Cholinesterase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Primary and secondary forms of pediatric intestinal pseudo‐obstruction (PIPO) are severe intestinal dysmotility disorders with a high risk of mortality and poor quality of life. Nutritional supports and current management have improved in part the prognosis, although several unmet needs challenge physicians. Prokinetic drugs may facilitate enteral nutrition (EN)/oral feeding (OF) and decrease parenteral nutrition (PN). Pyridostigmine has been effectively used in adults with severe gut dysmotility; however, experience in PIPO patients is still limited.

Methods

Patients intolerant to EN/OF in the previous 6 months were treated with pyridostigmine. We studied nutritional outcomes (caloric intake by EN/OF and PN as well as growth) at the beginning and after 6 and 12 months of pyridostigmine. Also, we collected clinical outcomes 12 months before and after pyridostigmine treatment.

Results

A total of 10 patients were included in the data analysis. Pyridostigmine (0.44–3.4 mg/Kg/day) resulted in a significant increase in EN tolerance: median caloric intake by EN/OF was >25% at 12 months ( p = 0.0156). In two patients, we achieved complete weaning from PN. In all patients, there was an amelioration of growth (increase in median weight z ‐score from −1.3 to −0.9) and a reduction in the number of hospitalizations and central line‐associated bloodstream infections in the year following pyridostigmine treatment. Only one patient developed pyridostigmine‐related bradycardia.

Conclusions

This study showed that pyridostigmine supported the nutritional management by improving EN/OF tolerance and reducing PN dependence. Our data provide a basis for future, ad hoc designed clinical trials testing pyridostigmine in PIPO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyridostigmine BromideIntestinal Pseudo-ObstructionEnteral NutritionCholinesterase InhibitorsHumansMaleFemaleChild, PreschoolChildInfantTreatment OutcomeAdolescentParenteral NutritionRetrospective Studies

Stichwörter der Autor:innen

artificial nutritionenteral nutrition (EN)intestinal failure (IF)nutritional disordersparenteral nutrition (PN)

Substanzen

Pyridostigmine BromideCholinesterase Inhibitors

Autor:innen und Institutionen

  • Gastroenterology and Nutritional Rehabilitation, "Bambino Gesù" Children's Hospital, IRCCS, Rome, Italy.
  • Department of Translational Science, University of Ferrara, Ferrara, Italy.
  • Anesthesia and Critical Care Medicine, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Gastroenterology and Nutrition Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
  • Neonatal Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Digestive Endoscopy and Surgery Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

ORCID-Profile: Teresa Capriati

Förderung

  • None

Zitieren

APA

Capriati, T., De Giorgio, R., Chiusolo, F., Tambucci, R., Fusaro, F., Caldaro, T., Trovato, C. M., Bonora, E., & Diamanti, A. (2025). Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo‐obstruction: A single‐center analysis. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70171

Vancouver

Capriati T, De Giorgio R, Chiusolo F, Tambucci R, Fusaro F, Caldaro T, et al. Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo‐obstruction: A single‐center analysis. Journal of Pediatric Gastroenterology and Nutrition. 2025. doi:10.1002/jpn3.70171

BibTeX
@article{Capriati2025,
  author = {Capriati, Teresa and De Giorgio, Roberto and Chiusolo, Fabrizio and Tambucci, Renato and Fusaro, Fabio and Caldaro, Tamara and Trovato, Chiara Maria and Bonora, Elena and Diamanti, Antonella},
  title = {Pyridostigmine improves feeding tolerance in pediatric intestinal pseudo‐obstruction: A single‐center analysis},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2025},
  doi = {10.1002/jpn3.70171}
}
Kostenlos starten →